Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

56.67

+0.34 (0.60%)

At close: Mar 23, 2026, 4:00 PM EDT

56.50

-0.17 (-0.30%)

Pre-market: Mar 24, 2026, 7:12 AM EDT

Revenue

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
GSK Revenue	-	2.65M	2.69M
GSK Revenue Growth	-	-1.49%	-90.95%
Takeda Revenue	-	-	866.00K
Takeda Revenue Growth	-	-	-99.47%
Sarepta Revenue	926.27M	696.80M	-
Sarepta Revenue Growth	32.93%	-	-
Sanofi Revenue	-	130.00M	-
Revenue (Other)	164.71M	-	-
Revenue (Total)	1.09B	829.45M	3.55M
Revenue (Total) Growth	31.53%	23258.15%	-98.52%

Updated Dec 31, 2025. Data Source: Fiscal.ai.